Эпилепсия и пароксизмальные состояния (Sep 2016)

EXPERIENCE OF TREATMENT WITH GENERIC LAMOTRIDJIN IN DIFFERENT FORMS OF EPILEPSY (The results of focus observation in out-patient clinics network of Moscow city public healthcare services)

  • O. L. Badalyan,
  • M. A. Bogomazova,
  • I. I. Zhuravleva,
  • A. M. Ismailov,
  • . .,
  • E. G. Komelkova,
  • L. N. Lesinker,
  • Yu. I. Logvinov,
  • O. V. Otcheskaya,
  • S. V. Petrov,
  • Yu. V. Solomatin,
  • A. M. Teplysheva,
  • T. N. Udovuchenko,
  • A. E. Khromykh,
  • A. S. Chukanova,
  • A. V. Lebedeva,
  • S. G. Burd,
  • A. N. Boiko

Journal volume & issue
Vol. 4, no. 4
pp. 40 – 48

Abstract

Read online

Focused observational study on efficacy, tolerability and quality of life in adult patients with different forms of epilepsy taking combined therapy with lamotrigine (Sazar). 32 patients (19 men and 13 women), 23-79 years old with focal forms (cryptogenic and symptomatic) epilepsy with different disease duration and presence of of different type and etiology seizures were enrolled into the study. Patients having been taken various antiepileptic drugs in monotherapy with different efficacy degree were observed. Patients sample included 20 patients, receiving valproic acid in various dosages and 12 patients, receiving topiramate. Sazar was added as a second drug with initial dosage of 25 mg daily. Results of focused observation allow us to make conclusion of possible expedience of Sazar indication, especially in patients in whom therapy with valproic acid is less effective.

Keywords